Biologicals In Oncology In-Depth Industrial and Market studies - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2017 - 2019
Albany, New York, Feb 03, 2017
"Biologicals
In Oncology Market - Global Industry Analysis, Size, Share, Growth,
Trends And Forecast, 2013 - 2019"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Biological
therapy is defined as use of living organisms and substances derived
from organism or synthetically produced version of such substances in
laboratories to treat the disease condition. Some of the biological
therapies for cancer involve vaccines or bacteria to stimulate the
body’s defense system to act against cancer cells. The biologicals
in oncology market is majorly differentiated into three major
segments, on the basis of biological, on the basis of development
stage and on the basis of pathway mapping involved in cancer therapy
investigation.
–
On the basis of type of biologicals available in market,
the market is further segmented as:
- Monoclonal antibodies
- Cytokine therapy
- Vaccine therapy
- Adoptive T-cell therapy
- Oncolytic virus therapy
- Gene therapy
- DNA oligonucleotide therapy
- RNA oligonucleotide therapy
There are at least 880
companies and their partners involved in developing around 1500 drugs
in developmental projects in cancer for the treatment of 132 tumor
and cancer types. The market for biologicals in oncology is going to
experience rapid growth as the prevalence of cancer all over the
world is increasing. But the major restraint involved in this market
is the fear from the side effects of the treatments as predicted by
clinical trials of the drugs as the therapies involving biological
lead to pain, swelling, redness, itchiness, soreness and rashes at
the site of infusion. Biologicals which provoke an immune system
response can even lead to risk of severe or even fatal
hypersensitivity reactions. The other major restraint in the market
is the high cost involved in the development and clinical trials of
the therapies. On the basis of development stage of drugs, the market
is segmented as follows:
- Marketed
- Registered
- Pre-registration
- Phase III clinical trials
- Phase II clinical trials
- Phase I clinical trials
- Preclinical trials
- No Data
- Suspended
- Ceased
The pathways that the drug follows are also
important for the market of biologicals in oncology. Pathway is the
chain of protein in the cell that communicates a signal from receptor
to the surface of DNA in nucleus of cell. This pathway consists of
many proteins, such as mitogen-activated protein kinases (MAPK) and
extracellular signal regulated kinases (ERK), these proteins help in
communication. When one of the protein is mutated, it leads to “on”
or “off” position. The therapy that reverse the “on” or “off”
situation is further investigated for cancer therapies. The
biologicals in oncology market are divided into four categories on
the basis of pathways involved in cancer therapy investigation which
are as follows:
- BioCarta pathways
- KEGG pathways
- NCI-Nature pathways
- NetPath pathways
North America currently
leads the market for biologicals in oncology followed by Europe and
Asia-Pacific due to awareness about therapies and support from
government to improve healthcare conditions. The market of
Asia-Pacific region is driven by Japan. Among the marketed and
registered therapies concerning biologicals in oncology, the market
of monoclonal antibodies therapy and vaccine therapy generates a
major part of revenue for the market because it increases chances of
uptake of cancerous tissue by increasing t1/2 in plasma, protects
normal tissues, improves uptake into cancer cells, enables escape
from lysosomes and provides long term drug release for low dose
drugs. The market players and institutes which are involved for
clinical trials and manufacturing biological include Astex
Therapeutics, F. Hoffmann - La Roche, Limited, Prometheus
Therapeutics and Diagnostics, Northwest Biotherapeutics, Merck and
Company, Immunovative Therapies, NewLink Genetics Corporation,
Limited, The University of Bologna Medical School, Rui Jin Hospital,
Klinikum der J.W. Goethe Universitaet, National Institute of Mental
Health, Peking University People\'s Hospital and Hadassah University
Hospital among others.
– This research report
analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under
this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
– This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a
complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the
coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed
profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players
and new entrants along with detailed value chain analysis.
– Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Comments
Post a Comment